Clinical Trials for Astellas

Explore 99 clinical trials worldwide

Showing 1-50 of 99 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Astellas

Clinical Trials (99)

NCT07139977
Study of EV for Recurrent Endometrial Carcinoma
PHASE2Not yet recruiting
12 participants
Started: Nov 1, 2025 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT06917313
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
PHASE2Not yet recruiting
92 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT07110038
DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
PHASE2Not yet recruiting
25 participants
Started: Oct 31, 2025 · Completed: Nov 30, 2030
1 condition4 sponsors1 location
NCT06396091
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer
PHASE1Recruiting
12 participants
Started: Sep 24, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor7 locations
NCT06956209
Akyva First In Human
NARecruiting
10 participants
Started: Sep 24, 2025 · Completed: Mar 31, 2027
1 condition3 sponsors1 location
NCT07140016
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
PHASE1Recruiting
40 participants
Started: Sep 22, 2025 · Completed: Dec 31, 2029
2 conditions1 sponsor2 locations
NCT07052929
Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators
PHASE1/PHASE2Recruiting
9 participants
Started: Sep 11, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT06957691
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
PHASE2Not yet recruiting
60 participants
Started: Aug 31, 2025 · Completed: Dec 31, 2028
19 conditions2 sponsors0 locations
NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
PHASE1Recruiting
364 participants
Started: Jul 25, 2025 · Completed: Apr 30, 2029
4 conditions1 sponsor4 locations
NCT07086651
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
N/ARecruiting
1,300 participants
Started: Jul 21, 2025 · Completed: Oct 31, 2025
4 conditions2 sponsors1 location
NCT07024615
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
PHASE1Recruiting
25 participants
Started: Jul 16, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor2 locations
NCT06970665
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
PHASE4Recruiting
20 participants
Started: Jul 8, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor12 locations
NCT06862219
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
PHASE4Recruiting
100 participants
Started: Jun 21, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors7 locations
NCT07005154
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
PHASE2Recruiting
218 participants
Started: Jun 19, 2025 · Completed: May 31, 2032
3 conditions1 sponsor4 locations
NCT06906822
PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
PHASE2Recruiting
60 participants
Started: Jun 10, 2025 · Completed: Jun 30, 2028
1 condition3 sponsors13 locations
NCT06901531
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
PHASE3Recruiting
500 participants
Started: May 22, 2025 · Completed: Dec 31, 2029
4 conditions1 sponsor78 locations
NCT06581146
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition
N/ARecruiting
50 participants
Started: May 19, 2025 · Completed: May 31, 2027
1 condition1 sponsor3 locations
NCT06809140
Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer
PHASE2Recruiting
47 participants
Started: Apr 7, 2025 · Completed: Nov 30, 2029
1 condition5 sponsors3 locations
NCT06902545
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
N/ARecruiting
377 participants
Started: Apr 3, 2025 · Completed: Jul 31, 2030
4 conditions1 sponsor10 locations
NCT06470282
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
PHASE1/PHASE2Recruiting
47 participants
Started: Mar 31, 2025 · Completed: Jan 31, 2028
4 conditions3 sponsors1 location
NCT06891560
A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
PHASE2Recruiting
34 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors7 locations
NCT06553885
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
PHASE2Recruiting
40 participants
Started: Mar 24, 2025 · Completed: Sep 30, 2029
2 conditions2 sponsors1 location
NCT06812754
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause
PHASE2Recruiting
150 participants
Started: Mar 10, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor27 locations
NCT06779773
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
N/ARecruiting
1,000 participants
Started: Jan 22, 2025 · Completed: Jan 31, 2030
2 conditions1 sponsor45 locations
NCT06130995
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
PHASE1Recruiting
46 participants
Started: Dec 26, 2024 · Completed: Jan 31, 2030
2 conditions3 sponsors1 location
NCT05656235
Renal Retention in High Grade Upper Tract Urothelial Cancer
PHASE2Recruiting
20 participants
Started: Nov 25, 2024 · Completed: Jun 30, 2029
3 conditions4 sponsors2 locations
NCT06394570
Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
PHASE1/PHASE2Recruiting
19 participants
Started: Sep 10, 2024 · Completed: Jul 1, 2027
1 condition2 sponsors1 location
NCT06544642
A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome
PHASE1Recruiting
132 participants
Started: Aug 21, 2024 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT06440967
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
PHASE3Recruiting
540 participants
Started: Jul 31, 2024 · Completed: Sep 30, 2028
1 condition1 sponsor98 locations
NCT06171178
A Study of ASP1012 in Adults With Solid Tumors
PHASE1Active, not recruiting
15 participants
Started: May 15, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor8 locations
NCT06364696
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
PHASE1Recruiting
175 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor7 locations
NCT05999747
A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney Disease
PHASE3Recruiting
94 participants
Started: Mar 19, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor11 locations
NCT05621616
A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity
PHASE3Active, not recruiting
7 participants
Started: Feb 28, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor7 locations
NCT06206421
A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause
PHASE3Active, not recruiting
277 participants
Started: Feb 22, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor24 locations
NCT06206408
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through Menopause
PHASE3Active, not recruiting
410 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor64 locations
NCT06150820
A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
NAActive, not recruiting
119 participants
Started: Feb 1, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor54 locations
NCT05970172
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
PHASE3Recruiting
100 participants
Started: Jan 16, 2024 · Completed: Sep 30, 2026
2 conditions1 sponsor45 locations
NCT06049797
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
N/AActive, not recruiting
998 participants
Started: Nov 15, 2023 · Completed: May 31, 2026
1 condition1 sponsor48 locations
NCT06011954
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
N/ARecruiting
202 participants
Started: Nov 1, 2023 · Completed: Jul 31, 2027
1 condition2 sponsors17 locations
NCT06099769
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
PHASE2Recruiting
201 participants
Started: Oct 18, 2023 · Completed: Oct 31, 2027
1 condition4 sponsors12 locations
NCT05879653
Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
PHASE2Recruiting
30 participants
Started: Oct 1, 2023 · Completed: Sep 30, 2027
1 condition6 sponsors4 locations
NCT05756569
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
PHASE2Recruiting
25 participants
Started: Sep 26, 2023 · Completed: Dec 16, 2027
11 conditions5 sponsors4 locations
NCT05756777
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
PHASE1Recruiting
36 participants
Started: Jun 26, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors7 locations
NCT05199051
A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults with FLT3-ITD Relapse/refractory (R/R) AML
PHASE2Recruiting
50 participants
Started: Jun 3, 2023 · Completed: Mar 15, 2027
1 condition4 sponsors30 locations
NCT05868265
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
PHASE2Recruiting
24 participants
Started: Jun 2, 2023 · Completed: Jun 2, 2026
1 condition2 sponsors7 locations
NCT05404139
Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
PHASE2Recruiting
132 participants
Started: May 24, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT05885009
Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)
N/ARecruiting
240 participants
Started: Mar 28, 2023 · Completed: Mar 28, 2028
1 condition7 sponsors1 location
NCT05719558
A Study of ASP1002 in Adults for Treatment of Solid Tumors
PHASE1Recruiting
210 participants
Started: Mar 13, 2023 · Completed: May 31, 2028
1 condition1 sponsor15 locations
NCT05520567
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
70 participants
Started: Jan 31, 2023 · Completed: Jul 31, 2028
2 conditions1 sponsor20 locations
NCT05382559
A Study of ASP3082 in Adults With Advanced Solid Tumors
PHASE1Recruiting
651 participants
Started: Jun 8, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor49 locations